Application Nr Approved Date Route Status External Links
NDA209321 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ruzurgi Is Indicated For The Treatment Of Lambert-Eaton Myasthenic Syndrome (lems) In Patients 6 To Less Than 17 Years Of Age. Ruzurgi Is A Potassium Channel Blocker Indicated For The Treatment Of Lambert-Eaton Myasthenic Syndrome (lems) In Patients 6 To Less Than 17 Years Of Age. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Amifampridine AMIFAMPRIDINE ZINC164000

Comments